DGX 178.22 (-0.16%)
US74834L1008Medical Diagnostics & ResearchDiagnostics & Research

Quest Diagnostics (DGX) Competitor Comparison

We are evaluating the key criteria listed to compare Quest Diagnostics (DGX) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - DGX ranking 36 / 58

These are the competitors of Quest Diagnostics in the industry Diagnostics & Research ranked by linearity 5 years
1. Co-Diagnostics CODX
100.26
2. Qiagen QGEN
81.5
3. Icon ICLR
49.86
4. Fulgent Genetics FLGT
37.71
5. Ortho Clinical Diagnostics Holdings OCDX
33.4
6. DarioHealth DRIO
31.71
7. IQVIA Holdings IQV
25.04
8. Syneos Health SYNH
24.79
9. Twist Bioscience TWST
21.87
10. DexCom DXCM
18.44
11. Charles River Laboratories CRL
17.61
12. Heska HSKA
15.42
13. Pacific Biosciences of California PACB
12.53
14. CareDx CDNA
10.95
15. Inotiv NOTV
10.45
16. Danaher DHR
9.32
17. Precipio PRPO
9.19
18. Thermo Fisher Scientific TMO
8.87
19. Anixa Biosciences ANIX
8.85
20. Agilent Technologies A
8.54
21. Olink Holding OLK
8.53
22. Mettler-Toledo MTD
7.45
23. Myriad Genetics MYGN
7.44
24. Aspira Womens Health AWH
5.9
25. IDEXX Laboratories IDXX
5.68
26. Exact Sciences EXAS
5.61
27. Guardant Health GH
5.23
28. PerkinElmer PKI
4.97
29. Trinity Biotech TRIB
4.91
30. Laboratory Corp of America Holdings LH
4.28
31. Personalis PSNL
4.27
32. Psychemedics PMD
3.78
33. Waters WAT
3.74
34. Enzo Biochem ENZ
3.59
35. NeoGenomics NEO
3.54
36. Quest Diagnostics DGX
3.37
37. Sotera Health SHC
3.17
38. Illumina ILMN
3.11
39. National Research NRC
2.96
40. Neogen NEOG
2.89
41. Bioventus BVS
2.51
42. Interpace Biosciences IDXG
2.45
43. Exagen XGN
2.35
44. Neuronetics STIM
2.28
45. Sera Prognostics SERA
2.24
46. Global Cord Blood CO
2.23
47. MaxCyte MXCT
1.92
48. MDxHealth MDXH
1.91
49. Biodesix BDSX
1.8
50. Prenetics Global PRE
1.72
51. bioAffinity Technologies BIAF
1.67
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Medpace Holdings MEDP
1.14
55. Meridian Bioscience VIVO
0.99
56. RadNet RDNT
0.75
57. Natera NTRA
0.68
58. Lantheus Holdings LNTH
0.31

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.